{"id":"https://openalex.org/W25479291","doi":null,"title":"The efficacy of twice daily cephalexin.","display_name":"The efficacy of twice daily cephalexin.","publication_year":1981,"publication_date":"1981-01-01","ids":{"openalex":"https://openalex.org/W25479291","mag":"25479291","pmid":"https://pubmed.ncbi.nlm.nih.gov/7267673"},"language":"en","primary_location":{"id":"pmid:7267673","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7267673","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmatherapeutica","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031654302","display_name":"A K Browning","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"A K Browning","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5031654302"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"2","issue":"9","first_page":"559","last_page":"64"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9794999957084656,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9794999957084656,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.01140000019222498,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10654","display_name":"Pneumonia and Respiratory Infections","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cephalexin","display_name":"cephalexin","score":1.0},{"id":"https://openalex.org/keywords/twice-daily-dosing","display_name":"twice-daily dosing","score":0.8370000123977661},{"id":"https://openalex.org/keywords/respiratory-tract-infections","display_name":"respiratory infections","score":0.8230000138282776},{"id":"https://openalex.org/keywords/soft-tissue-infection","display_name":"soft tissue infection","score":0.9959999918937683},{"id":"https://openalex.org/keywords/general-practice","display_name":"general practice","score":0.5320000052452087},{"id":"https://openalex.org/keywords/clinical-efficacy","display_name":"clinical efficacy","score":0.5699999928474426},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.5740000009536743},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.656000018119812}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7624470591545105},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6816473007202148},{"id":"https://openalex.org/C65409693","wikidata":"https://www.wikidata.org/wiki/Q425265","display_name":"Statistical significance","level":2,"score":0.5485447645187378},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.5458987951278687},{"id":"https://openalex.org/C534529494","wikidata":"https://www.wikidata.org/wiki/Q7891","display_name":"Respiratory system","level":2,"score":0.4902046322822571},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.48223552107810974},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46099308133125305},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.34084850549697876},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002506","descriptor_name":"Cephalexin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D002506","descriptor_name":"Cephalexin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012141","descriptor_name":"Respiratory Tract Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:7267673","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7267673","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmatherapeutica","raw_type":"Clinical Trial"},{"id":"mag:25479291","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7267673","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":48,"referenced_works":["https://openalex.org/W51501712","https://openalex.org/W68902997","https://openalex.org/W1975755498","https://openalex.org/W1976427299","https://openalex.org/W1978557841","https://openalex.org/W1982435579","https://openalex.org/W1987183608","https://openalex.org/W1994577768","https://openalex.org/W1995306788","https://openalex.org/W2000574715","https://openalex.org/W2008848202","https://openalex.org/W2012682248","https://openalex.org/W2017268162","https://openalex.org/W2017648684","https://openalex.org/W2020687317","https://openalex.org/W2020858070","https://openalex.org/W2022269438","https://openalex.org/W2039993818","https://openalex.org/W2040320188","https://openalex.org/W2043342723","https://openalex.org/W2044491984","https://openalex.org/W2044492613","https://openalex.org/W2045848891","https://openalex.org/W2046182010","https://openalex.org/W2049062332","https://openalex.org/W2055280773","https://openalex.org/W2066383233","https://openalex.org/W2068250936","https://openalex.org/W2070497945","https://openalex.org/W2074133251","https://openalex.org/W2077311976","https://openalex.org/W2079012338","https://openalex.org/W2083473113","https://openalex.org/W2087382711","https://openalex.org/W2090764318","https://openalex.org/W2092183084","https://openalex.org/W2092509345","https://openalex.org/W2099059847","https://openalex.org/W2104883826","https://openalex.org/W2109424626","https://openalex.org/W2113155921","https://openalex.org/W2144714391","https://openalex.org/W2151459749","https://openalex.org/W2169086780","https://openalex.org/W2267681188","https://openalex.org/W2313170633","https://openalex.org/W4249432966","https://openalex.org/W6777125321"],"related_works":["https://openalex.org/W2331865705","https://openalex.org/W2043258675","https://openalex.org/W2434243593","https://openalex.org/W155111921","https://openalex.org/W1970364461","https://openalex.org/W2162498046","https://openalex.org/W4231081322","https://openalex.org/W7099151268","https://openalex.org/W2405385937","https://openalex.org/W2084389063"],"abstract_inverted_index":{"A":[0],"multi-centre":[1],"study":[2],"in":[3,24,106,112,124],"general":[4],"practice":[5],"was":[6,103,141],"carried":[7],"out":[8],"to":[9,30,128],"compare":[10],"the":[11,45,56,61,88,125,137],"efficacy":[12],"of":[13,16,44,139],"two":[14,57],"doses":[15],"cephalexin-500":[17],"mg":[18],"or":[19,35,49],"1":[20,69],"g":[21,70],"-":[22],"given":[23],"a":[25,75,83],"twice":[26,72],"daily":[27,73,100],"dosage":[28],"regimen":[29],"752":[31],"patients":[32,46,107,114],"with":[33,52,87,108,120],"respiratory":[34,63],"soft":[36,65],"tissue":[37,66],"infections.":[38],"After":[39],"5-days'":[40],"treatment,":[41,81],"over":[42],"80%":[43],"were":[47,134],"cured":[48],"considerably":[50],"improved,":[51],"no":[53],"differences":[54],"between":[55],"treatment":[58],"groups.":[59],"Considering":[60],"lower":[62],"and":[64,111,136],"infections":[67],"together,":[68],"cephalexin":[71,101],"produced":[74],"better":[76],"clinical":[77],"response":[78,86],"after":[79],"48-hours'":[80],"suggesting":[82],"more":[84],"rapid":[85],"higher":[89],"dosage,":[90],"but":[91],"this":[92],"trend":[93],"did":[94],"not":[95],"reach":[96],"statistical":[97],"significance.":[98],"Twice":[99],"therapy":[102,123],"also":[104],"effective":[105],"concurrent":[109],"illness,":[110],"those":[113],"who":[115],"had":[116],"been":[117],"treated":[118],"unsuccessfully":[119],"other":[121],"antibacterial":[122],"week":[126],"prior":[127],"trial":[129],"entry.":[130],"No":[131],"drug":[132],"interactions":[133],"reported":[135],"incidence":[138],"side-effects":[140],"low.":[142]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}